These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
110 related articles for article (PubMed ID: 29311397)
61. [Clinical efficacy and prognostic factors analysis following curative hepatectomy for hepatocellular carcinoma patients with different China Liver Cancer Staging]. Li CX; Zhang H; Wu XF; Han S; Jiao CY; Wang D; Wang K; Li XC Zhonghua Wai Ke Za Zhi; 2021 Feb; 59(2):134-143. PubMed ID: 33378806 [No Abstract] [Full Text] [Related]
62. Hangzhou criteria for liver transplantation in hepatocellular carcinoma: a single-center experience. Lei JY; Wang WT; Yan LN Eur J Gastroenterol Hepatol; 2014 Feb; 26(2):200-4. PubMed ID: 23995766 [TBL] [Abstract][Full Text] [Related]
63. Prognostic factors of disease-free and overall survival in patients with hepatocellular carcinoma undergoing partial hepatectomy in curative intent. Lurje G; Bednarsch J; Czigany Z; Amygdalos I; Meister F; Schöning W; Ulmer TF; Foerster M; Dejong C; Neumann UP Langenbecks Arch Surg; 2018 Nov; 403(7):851-861. PubMed ID: 30267147 [TBL] [Abstract][Full Text] [Related]
64. Prognostic factors in the surgical treatment of caudate lobe hepatocellular carcinoma. Liu P; Yang JM; Niu WY; Kan T; Xie F; Li DQ; Wang Y; Zhou YM World J Gastroenterol; 2010 Mar; 16(9):1123-8. PubMed ID: 20205285 [TBL] [Abstract][Full Text] [Related]
65. Impact of postoperative infective complications on long-term survival after liver resection for hepatocellular carcinoma. Yang T; Liu K; Liu CF; Zhong Q; Zhang J; Yu JJ; Liang L; Li C; Wang MD; Li ZL; Wu H; Xing H; Han J; Lau WY; Zeng YY; Zhou YH; Gu WM; Wang H; Chen TH; Zhang YM; Zhang WG; Pawlik TM; Wu MC; Shen F Br J Surg; 2019 Aug; 106(9):1228-1236. PubMed ID: 31276196 [TBL] [Abstract][Full Text] [Related]
68. Correlation between smoking habit and surgical outcomes on viral-associated hepatocellular carcinomas. Kai K; Komukai S; Koga H; Yamaji K; Ide T; Kawaguchi A; Aishima S; Noshiro H World J Gastroenterol; 2018 Jan; 24(1):58-68. PubMed ID: 29358882 [TBL] [Abstract][Full Text] [Related]
69. Tumor size as a prognostic factor in resected small hepatocellular carcinoma: a controversy revisited. Chen YL; Ko CJ; Chien SY; Chen LS; Chen ML; Chi CW; Lai HW J Gastroenterol Hepatol; 2011 May; 26(5):851-7. PubMed ID: 21129015 [TBL] [Abstract][Full Text] [Related]
70. The prognostic value of microvascular invasion in early-intermediate stage hepatocelluar carcinoma: a propensity score matching analysis. Shen J; Wen J; Li C; Wen T; Yan L; Li B; Yang J; Lu C BMC Cancer; 2018 Mar; 18(1):278. PubMed ID: 29530006 [TBL] [Abstract][Full Text] [Related]
71. Living donor liver transplantation or resection for Child-Pugh A hepatocellular carcinoma patients with multiple nodules meeting the Milan criteria. Jiang L; Liao A; Wen T; Yan L; Li B; Yang J Transpl Int; 2014 Jun; 27(6):562-9. PubMed ID: 24606007 [TBL] [Abstract][Full Text] [Related]
72. Major hepatectomy is safe for hepatocellular carcinoma in elderly patients with cirrhosis. Wang WL; Zhu Y; Cheng JW; Li MX; Xia JM; Hao J; Yu L; Lv Y; Wu Z; Wang B Eur J Gastroenterol Hepatol; 2014 Apr; 26(4):444-51. PubMed ID: 24463566 [TBL] [Abstract][Full Text] [Related]
73. Fresh frozen plasma transfusion does not affect outcomes following hepatic resection for hepatocellular carcinoma. Tomimaru Y; Wada H; Marubashi S; Kobayashi S; Eguchi H; Takeda Y; Tanemura M; Noda T; Umeshita K; Doki Y; Mori M; Nagano H World J Gastroenterol; 2010 Nov; 16(44):5603-10. PubMed ID: 21105194 [TBL] [Abstract][Full Text] [Related]
74. Infiltrative Hepatocellular Carcinoma: Assessment of Factors Associated With Outcomes in Patients Undergoing Hepatectomy. Yan X; Fu X; Deng M; Chen J; He J; Shi J; Qiu Y Medicine (Baltimore); 2016 May; 95(19):e3589. PubMed ID: 27175659 [TBL] [Abstract][Full Text] [Related]
75. Preoperative galactose elimination capacity predicts complications and survival after hepatic resection. Redaelli CA; Dufour JF; Wagner M; Schilling M; Hüsler J; Krähenbühl L; Büchler MW; Reichen J Ann Surg; 2002 Jan; 235(1):77-85. PubMed ID: 11753045 [TBL] [Abstract][Full Text] [Related]
76. Liver resection for hepatocellular carcinoma: personal experiences in a series of 1330 consecutive cases in China. Li J; Huang L; Yan J; Qiu M; Yan Y ANZ J Surg; 2018 Oct; 88(10):E713-E717. PubMed ID: 29363237 [TBL] [Abstract][Full Text] [Related]
77. Efficiency and safety of radiofrequency-assisted hepatectomy for hepatocellular carcinoma with cirrhosis: A single-center retrospective cohort study. Zhang F; Yan J; Feng XB; Xia F; Li XW; Ma KS; Bie P World J Gastroenterol; 2015 Sep; 21(35):10159-65. PubMed ID: 26401080 [TBL] [Abstract][Full Text] [Related]
78. The FIB-4 score predicts postoperative short-term outcomes of hepatocellular carcinoma fulfilling the milan criteria. Dong J; Xu XH; Ke MY; Xiang JX; Liu WY; Liu XM; Wang B; Zhang XF; Lv Y Eur J Surg Oncol; 2016 May; 42(5):722-7. PubMed ID: 26927299 [TBL] [Abstract][Full Text] [Related]
79. Microvascular invasion patterns affect survival in hepatocellular carcinoma patients after second hepatectomy. Hou YF; Wei YG; Yang JY; Wen TF; Xu MQ; Yan LN; Li B; Chen KF J Surg Res; 2016 Jan; 200(1):82-90. PubMed ID: 26259778 [TBL] [Abstract][Full Text] [Related]
80. Outcome after partial hepatectomy for hepatocellular cancer within the Milan criteria. Fan ST; Poon RT; Yeung C; Lam CM; Lo CM; Yuen WK; Ng KK; Liu CL; Chan SC Br J Surg; 2011 Sep; 98(9):1292-300. PubMed ID: 21656513 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]